Featured Research

from universities, journals, and other organizations

Women fight the effects of chemotherapy long after treatment ends

Date:
October 20, 2010
Source:
University of Missouri-Columbia
Summary:
For some women, the effects of breast cancer, the most common cancer affecting women, do not end when they leave the hospital. Now, researchers have studied the lives of breast cancer patients following chemotherapy and found that their environments and available support systems help determine the quality of their lives.

For some women, the effects of breast cancer, the most common cancer affecting women, do not end when they leave the hospital. Now, researchers in the University of Missouri School of Health Professions have studied the lives of breast cancer patients following chemotherapy and found that their environments and available support systems help determine the quality of their lives.

"A lot of times people get mentally and emotionally ready to deal with chemotherapy and they receive a lot of support during that time," said Stephanie Reid-Arndt, an assistant professor of health psychology in the School of Health Professions. "Then they go home and everyone feels like it's over, but the patients still have worries and fears about the changes they've been through and what it means for the future."

The study found that people reluctant to seek out social support, including therapy and informal support networks, following chemotherapy reported a lower quality of life and higher incidences of depression. A lot of people have trouble reaching out to a support network, don't know how, don't want to bother people or simply don't want to share their problems, Reid-Arndt said.

The patients' homes also were found to be a factor as the study reported a lower quality of life and functional well-being for women returning to rural areas after chemotherapy. Women in rural areas also reported increased breast cancer related symptoms such as body-image issues and fatigue.

It isn't all bad news for patients from rural communities though. People in rural communities value close relationships with family, the community and religious organizations and find solace in these support systems after chemotherapy, according to research on this topic.

"There tends to be strong community support for patients in rural areas that will accommodate varying levels of function," Reid-Arndt said. "Unfortunately, while this informal support system provides great comfort to patients, it lacks formal mental health and health issues knowledge available from health care professionals."

Reid-Arndt hypothesizes that due to proximity to more mental health services, those returning home to urban areas after breast cancer treatment may suffer less symptoms of depression and a higher quality of life, provided they seek professional support.


Story Source:

The above story is based on materials provided by University of Missouri-Columbia. Note: Materials may be edited for content and length.


Cite This Page:

University of Missouri-Columbia. "Women fight the effects of chemotherapy long after treatment ends." ScienceDaily. ScienceDaily, 20 October 2010. <www.sciencedaily.com/releases/2010/10/101020121316.htm>.
University of Missouri-Columbia. (2010, October 20). Women fight the effects of chemotherapy long after treatment ends. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2010/10/101020121316.htm
University of Missouri-Columbia. "Women fight the effects of chemotherapy long after treatment ends." ScienceDaily. www.sciencedaily.com/releases/2010/10/101020121316.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins